Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Using financial plans to reach life objectives can streamline your path to success. Discover how to create a plan that works for you.
22,378 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Turn a few pages into a powerful investing habit. This guide shows how to structure your Thursday reads routine, pick...
A surprise take-private bid sent AES stock tumbling and left investors wondering what comes next. This guide breaks d...
The Postmaster General warns the postal service will cash out within 12 months unless Congress lifts the borrowing ca...
Dividend income can weather downturns better than stocks, but it isn’t immune. This report explains why payouts hold ...
Investing in AI stocks can be high reward but requires focus. This guide breaks down five top AI stocks to buy now, w...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Royal Caribbean enters 2026 with strong demand, but fuel cost headwinds and a heavy capex slate threaten margins, rem...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Bank of America economists say the Fed is unlikely to cut rates until 2027, a forecast that could influence mortgages...
Berkshire Hathaway is sitting on an enormous cash reserve. Far from a weakness, that cash pile gives the company dry ...
A $2.2 million dividend portfolio is quietly generating $13,200 a month in cash flow while avoiding complex K-1 taxes...